| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |